Evoke Pharma (EVOK) Misses Q3 EPS by 95c

Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.94), $0.95 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $2.65 million versus the consensus estimate of $4.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
• PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
• After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE